Oric Pharmaceuticals Inc. (ORIC) News
Filter ORIC News Items
ORIC News Results
| Date | Symbol | Company | Title | Start | End | Change | POWR Rating | ||
|---|---|---|---|---|---|---|---|---|---|
| Loading, please wait... | |||||||||
ORIC News Highlights
- For ORIC, its 30 day story count is now at 6.
- Over the past 25 days, the trend for ORIC's stories per day has been choppy and unclear. It has oscillated between 1 and 3.
- The most mentioned tickers in articles about ORIC are COMP and TREX.
Latest ORIC News From Around the Web
Below are the latest news stories about Oric Pharmaceuticals Inc that investors may wish to consider to help them evaluate ORIC as an investment opportunity.
2 Falling Knives to CatchORIC Pharmaceuticals Inc. and Ondas Holdings Inc. have positive ratings despite falling more than 59% over the past year |
ORIC Pharmaceuticals to Participate in the Guggenheim 2022 Oncology ConferenceSOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Feb. 02, 2022 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that management will participate in a virtual fireside chat at the Guggenheim 2022 Oncology Conference on Thursday, February 10, 2022, at 2:00 p.m. ET. A live webcast of the fireside chat will be available through the investor section of the comp |
Emerald Advisers, Llc Buys Customers Bancorp Inc, Herc Holdings Inc, ACADIA Pharmaceuticals ...Investment company Emerald Advisers, Llc (Current Portfolio) buys Customers Bancorp Inc, Herc Holdings Inc, ACADIA Pharmaceuticals Inc, HireRight Holdings Corp, Arhaus Inc, sells Chegg Inc, ORIC Pharmaceuticals Inc, BellRing Brands Inc, Trex Co Inc, Arena Pharmaceuticals Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Emerald Advisers, Llc. |
Emerald Mutual Fund Advisers Trust Buys Customers Bancorp Inc, Herc Holdings Inc, ACADIA ...Leola, PA, based Investment company Emerald Mutual Fund Advisers Trust (Current Portfolio) buys Customers Bancorp Inc, Herc Holdings Inc, ACADIA Pharmaceuticals Inc, Karuna Therapeutics Inc, HireRight Holdings Corp, sells Chegg Inc, BellRing Brands Inc, Echo Global Logistics Inc, Tetra Tech Inc, ORIC Pharmaceuticals Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Emerald Mutual Fund Advisers Trust. |
Companies Like ORIC Pharmaceuticals (NASDAQ:ORIC) Are In A Position To Invest In GrowthThere's no doubt that money can be made by owning shares of unprofitable businesses. For example, although... |
10 Best Biotech and AI Stocks To Buy According To Quant Billionaire Jim SimonsEuclidean Capital is the family office of billionaire hedge fund manager James “Jim” Simons. The hedge fund manages the private fortunes of Jim Simons, the 28th richest person in the world with a personal net worth of $24.4 billion as of January 28. Jim Simons is said to have revolutionized investing when he left academics […] |
ORIC Pharmaceuticals Announces Regulatory Clearance of Clinical Trial Application for ORIC-114 in Advanced Solid Tumors with EGFR or HER2 Exon 20 Alterations or HER2 AmplificationsSOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 25, 2022 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced clearance of its Clinical Trial Application (CTA) by the regulatory authorities of the Republic of Korea for ORIC-114, a brain penetrant, orally bioavailable, irreversible inhibitor designed to selectively target EGFR and HER2 with high potency a |
Regents Of The University Of California Buys Unity Software Inc, Airbnb Inc, QuantumScape Corp, ...Oakland, CA, based Investment company Regents Of The University Of California (Current Portfolio) buys Unity Software Inc, Airbnb Inc, QuantumScape Corp, ORIC Pharmaceuticals Inc, Calyxt Inc, sells Upstart Holdings Inc, Nurix Therapeutics Inc, RAPT Therapeutics Inc, Pinduoduo Inc, View Inc during the 3-months ended 2021Q4, according to the most recent filings of the investment company, Regents Of The University Of California. |
ORIC Pharmaceuticals Provides Corporate Update and Highlights Key Upcoming MilestonesORIC-101 program on track for updates from both ongoing clinical trials in first half of 2022 Initial Phase 1b data from ORIC-533 in multiple myeloma, ORIC-114 in EGFR/HER2 cancers and ORIC-944 in prostate cancer expected in first half of 2023 Cash and investments of $280.8 million expected to fund operating plan into first half of 2024 SOUTH SAN FRANCISCO, Calif. and SAN DIEGO, Jan. 10, 2022 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused |
ORIC Pharmaceuticals to Present at the 40th Annual J.P. Morgan Healthcare ConferenceSOUTH SAN FRANCISCO and SAN DIEGO, Calif., Jan. 04, 2022 (GLOBE NEWSWIRE) -- ORIC Pharmaceuticals, Inc. (Nasdaq: ORIC), a clinical stage oncology company focused on developing treatments that address mechanisms of therapeutic resistance, today announced that Jacob Chacko, M.D., chief executive officer, will present a company overview at the 40th Annual J.P. Morgan Healthcare Conference on Tuesday, January 11, 2022, at 3:00 p.m. ET. A live webcast of the company presentation will be available thr |